Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis-Reference-Cited by-同舟云学术

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

Published:2013-06-06 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Filippini Graziella¹,Del Giovane Cinzia²,Vacchi Laura³,D'Amico Roberto²,Di Pietrantonj Carlo⁴,Beecher Deirdre⁵,Salanti Georgia⁶

Affiliation:

1. Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Neuroepidemiology Unit; via Celoria, 11 Milano Italy 20133

2. University of Modena and Reggio Emilia; Statistics Unit, Department of Clinical and Diagnostic Medicine and Public Health; Modena Italy

3. Scientific Institute and University Ospedale San Raffaele; Institute of Experimental Neurology (INSPE); via Olgettina 58 Milano Italy

4. Azienda Sanitaria Locale ASL AL; Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi-SeREMI - Cochrane Vaccines Field; Via Venezia 6 Alessandria Piemonte Italy 15100

5. London School of Hygiene & Tropical Medicine; Cochrane Injuries Group; Keppel Street London UK WC1E 7HT

6. University of Ioannina School of Medicine; Department of Hygiene and Epidemiology; Medical School Campus University of Ioannina Ioannina Greece 45110

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD008933.pub2/fullpdf

Reference155 articles.

1. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses;Achiron;Neurology,1998

2. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;The New England Journal of Medicine,2006

3. Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis;Andersen;Journal of Neurology, Neurosurgery, and Psychiatry,2004

4. 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study;O'Connor;Lancet Neurology,2009

5. Bornstein MB Miller A Slagle S Weitzman M Crystal A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis The New England Journal of Medicine 1987 408 14

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-09-10

2. Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2024-04

3. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-04

4. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-11-30

5. Safety and Effectiveness of Cinnomer^® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study;Archives of Iranian Medicine;2023-11-01